Media Center

Decentralized trials have a new home in Sun City Center, Florida. On November 3, Care Access held a ribbon cutting ceremony for a new research site in the active living senior community. The Sun City Chamber of Commerce and local business leaders joined the Care Access team in celebrating the new research facility. It is the first in a network of purpose-built sites for an Alzheimer’s prevention study.

(BUSINESS WIRE) — Care Access, the world's leader in executing decentralized clinical trials at scale, has announced its upcoming involvement at four key industry conferences: CNS Summit, Outsourcing in Clinical Trials New England (OCTNE), Decentralized Trials & Research Alliance Annual Meeting (DTRA), and Decentralized Trials Digital Week.

(BUSINESS WIRE) -- Care Access, the world’s leading decentralized research organization (DRO), today announced its expanded partnership with global biopharma leader Eli Lilly and Company (Lilly) to broaden patient access to clinical trials and increase representation of minority group members, including African American, Hispanic, and LatinX populations.

Taking research sites directly to local communities may hold the key to decreasing patient burden. An estimated 70 percent of potential trial participants live over two hours away from the nearest research center, forcing many to think twice about enrolling in a clinical study.¹ Traveling to distant research sites can be time-consuming, costly and, in some cases, nearly impossible for certain patients due to health concerns, work and childcare responsibilities, and lack of access to transportation.

Care Access CEO and Co-Founder Ahmad Namvargolian is on a mission to remove barriers to clinical trials for sponsors, physicians and patients, and to make research studies accessible for all. This mission was put to the test in the spring of 2020, when the COVID-19 pandemic sent the world screeching to a halt.